Gxs Therapeutics Limited
16058510
Healthy
- Negative net worth (-10)
Details
Compliance
Next accounts due
04/08/2026
Confirmation statement
Last: 03/11/2025
Due 17/11/2026
Industry
Officers
director · Since 04/11/2024
COMPANY DIRECTOR
BRITISH · ENGLAND · Age 36
Persons with Significant Control
Elements Squared Limited
The Cambridge Partnership, The Dorothy Hodgkin Building, Cambridge, CB22 3FH
Reg: 12065441 · Companies House · Limited Company
Notified 26/03/2025
Former PSCs
Dr Joao Victor De Souza Cunha
Ceased 26/03/2025
Dr Jonathan Richard Heal
Ceased 26/03/2025
CompanyRankvs 1621+ SIC 72110 peers50
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 30/11/2025
Net Worth
-£59k
Balance sheet strength
Cash
£2k
Cash in the bank
Net Current Assets
£22k
Working capital
Current Assets
£24k
Current Liabilities
£2k
Debtors
£22k
Balance Sheet
EstimatesDerived
| Year | Current Ratio |
|---|---|
| 2025 | 10.44 |
Derived from filed accounts. Not audited figures.